Hypermetropia, Myopia, Myopic Astigmatism, Refractive Errors
Conditions
Keywords
refractive errors, myopia, hypermetropia, astigmatism, refractive surgery, ICL, ophthalmic viscosurgical device
Brief summary
The goal of this observational study is to test whether surgeries for lenses designed to be implanted in the eye to correct refractive error can be done without the need for using viscoelastic substances that are used routinely nowadays to make it easier to introduce them inside the human eye and protect the inside of the eye during the operation. The main question it aims to answer is that is it safe to do the surgery without using them? to answer this question researchers will access recorded data of patients that underwent refractive surgeries in a private clinic since 2017 and compare them as two groups: those who underwent the traditional procedures and those who had it without the use of dispersive viscoelastics in regard to their vision before and after surgery, their ocular pressure and biomicroscopic analysis of the inside of their corneas before and after surgery.
Detailed description
Records of patients that had undergone ICL implantation surgery in Al-Ferdows private eye hospital in Baghdad between 2017 and 2023 were accessed. Two groups of patients were identified, for the first group the ICL was implanted with the use of both dispersive and cohesive OVDs (traditional OVD group) and for the second one a novel method of implantation was used without utilizing dispersive OVD (reduced OVD) group. Both types of surgery were done by the same surgeon and in the same settings. The operative notes of the OVD group were as follows: under topical anesthesia if the ICL is toric, manual corneal marking is done in the sitting position using pendular marker. After loading of the ICL, two-step clear corneal main incision 2.8 mm in width with a bit long track of 1.5-2 mm to enhance its valve action was fashioned. Intracameral injection of dispersive OVD. The ICL was implanted with mouth-to-mouth technique. Anterior chamber reformation with cohesive OVD, then haptics are gently pushed behind the iris using an olive-tipped manipulator, ensuring alignment to proper axis in case of toric ICL, otherwise spherical ICL is placed directly at 180° axis. After that, AC (anterior chamber) wash with irrigation/aspiration is performed then stromal hydration was done to seal the surgical wound. In the reduced OVD group, modification to the traditional method involved omitting the step of dispersive OVD injection and instead utilizing Intracameral injection of 1:1 mixture of 1:1000 adrenaline and 2% lidocaine in an overfilling manner. All other surgical steps are performed in an identical manner. The study was ethically approved by the institutional review committee at the respective hospital and a similar committee at the college of medicine of university of Basrah according to the local guidelines and protocols. Written informed consent was obtained from each patient before the surgery. The study followed tenets of declaration of Helsinki. For both groups, records involving preoperative and postoperative assessments such as uncorrected and best corrected visual acuity, refractive error quantification both objectively utilizing an autorefractometer autorefractor Nidek ARK 1 (Nidek Inc, Gamagori, Japan) and subjectively as manifest refraction, clinical slit-lamp examination notes, intraocular pressure with non-contact air puff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan), AC depth assessment by Pentacam Scheimpflug (Oculus Optikgeräte GmbH Inc., Wetzlar, Germany), specular microscopy study of corneal endothelial cells (endothelial cell density (ECD), coefficient of variation (CV) and hexagonality) using Topcon SP-1p Specular Microscope (Topcon Corporation, Tokyo, Japan), were accessed and analyzed using the latest software in SPSS. Patients with missing or incomplete data were excluded from the study. Exclusion criteria also included patients with severe ocular surface disease, unstable refraction, glaucoma, cataract, retinal detachment and uveitis. Unpaired t test or Mann-Whitney test was used to compare the two groups according to fulfilled statistical assumptions. Significance was considered at P value less than 0.05.
Interventions
patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD
patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD.
Sponsors
Study design
Eligibility
Inclusion criteria
* Inclusion Criteria: * patients with refractive errors and stable refraction seeking refractive surgery who are fit for phakic IOL (intraocular lens) implantation and having reasonable improvement of visual acuity with refractive correction.
Exclusion criteria
* patients with severe ocular surface disease, unstable refraction, glaucoma, cataract, retinal detachment and uveitis.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Unaided Visual Acuity After the Procedure | 1-2 years after the surgery | visual acuity (vision of the patient) without use of any glasses measured using LogMar charts. This measure has no specified units |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraocular Pressure Postoperatively | first day, first week and first month after the procedure | intraocular pressure in mmHg as measured by non-contact airpuff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan). intraocular pressure is measured in millimeters of mercury |
| Specular Microscopy Parameter: Endothelial Cell Density | 1-2 years after the surgery | defined as the number of corneal endothelial cells per square millimeter of area, measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan) |
| Specular Microscopy Parameter: Endothelial Cells Hexagonality | 1-2 years after the surgery | defined as the percentage of endothelial cells having 6 borders and shaped like a hexagon. this measure reflects the overall health of the endothelial cells and decreased hexagonality below 58-60% indicates corneal enodthelial pleomorphism, also measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan) |
| Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells | 1-2 years after the surgery | The standard deviation of the mean cell area divided by the mean cell area gives the coefficient of variation, a unitless number that is normally less than 0.30. it reflects the health of endothelial cells and measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan). |
Other
| Measure | Time frame | Description |
|---|---|---|
| Postoperative Complications | any time post op within the maximum 2 years follow up period | such as glaucoma, cataract, persistent uveitis, macular edema, endophthalmitis..etc. |
Countries
Iraq
Participant flow
Recruitment details
Data from all patients that had undergone ICL implantation surgery for the correction of refractive errors in Al-Ferdows private eye hospital in Baghdad between 2017 and 2023 were accessed.
Pre-assignment details
The majority of the enrolled subjects were excluded from the study because most of their data were missing in the records. They cannot be analyzed as per study protocol
Participants by arm
| Arm | Count |
|---|---|
| Traditional OVD Group In this group of patients, the ICL was implanted utilizing both cohesive and dispersive ophthalmic viscosurgical device.
phakic intraocular lens implantation traditional: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD | 46 |
| Traditional OVD Group In this group of patients, the ICL was implanted utilizing both cohesive and dispersive ophthalmic viscosurgical device.
phakic intraocular lens implantation traditional: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD | 78 |
| Reduced OVD Group In this group of patients, the ICL was implanted with the use of cohesive OVD only.
phakic intraocular lens implantation reduced OVD: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD. | 67 |
| Reduced OVD Group In this group of patients, the ICL was implanted with the use of cohesive OVD only.
phakic intraocular lens implantation reduced OVD: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD. | 121 |
| Total | 312 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Missing data | 88 | 247 |
Baseline characteristics
| Characteristic | Traditional OVD Group | Total | Reduced OVD Group |
|---|---|---|---|
| Age, Continuous | 32.04 years STANDARD_DEVIATION 7.39 | 30.23 years STANDARD_DEVIATION 7.9 | 29.07 years STANDARD_DEVIATION 8.04 |
| Anterior Chamber Depth | 3.279 Millimeter STANDARD_DEVIATION 0.299 | 3.297 Millimeter STANDARD_DEVIATION 0.265 | 3.308 Millimeter STANDARD_DEVIATION 0.241 |
| Best-corrected Visual acuity | .33 LogMAR STANDARD_DEVIATION 0.12 | .33 LogMAR STANDARD_DEVIATION 0.11 | .33 LogMAR STANDARD_DEVIATION 0.11 |
| Central corneal thickness | 493.0 micrometer STANDARD_DEVIATION 38.83 | 492.3 micrometer STANDARD_DEVIATION 42.86 | 491.8 micrometer STANDARD_DEVIATION 45.6 |
| Corneal endothelial cells hexagonality | 58.22 percentage STANDARD_DEVIATION 10.55 | 58.27 percentage STANDARD_DEVIATION 10.07 | 58.30 percentage STANDARD_DEVIATION 9.77 |
| Corneal endothelial coefficient of variation | 29.6 unitless STANDARD_DEVIATION 4.4 | 29.6 unitless STANDARD_DEVIATION 4.1 | 29.6 unitless STANDARD_DEVIATION 3.9 |
| Endothelial Cell Density | 2793.75 cells per square millimeter STANDARD_DEVIATION 310.6 | 2861.47 cells per square millimeter STANDARD_DEVIATION 312.6 | 2904.56 cells per square millimeter STANDARD_DEVIATION 307.4 |
| Intraocular pressure | 15.22 Millimeters of Mercury STANDARD_DEVIATION 1.9 | 15.98 Millimeters of Mercury STANDARD_DEVIATION 2.4 | 16.79 Millimeters of Mercury STANDARD_DEVIATION 2.7 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 46 Participants | 113 Participants | 67 Participants |
| Region of Enrollment Iraq | 46 participants | 113 participants | 67 participants |
| Sex: Female, Male Female | 56 eyes | 135 eyes | 79 eyes |
| Sex: Female, Male Male | 22 eyes | 64 eyes | 42 eyes |
| Unaided visual acuity | 1.170 LogMAR STANDARD_DEVIATION 0.196 | 1.175 LogMAR STANDARD_DEVIATION 0.2 | 1.177 LogMAR STANDARD_DEVIATION 0.21 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 46 | 0 / 67 |
| other Total, other adverse events | 1 / 46 | 0 / 67 |
| serious Total, serious adverse events | 0 / 46 | 0 / 67 |
Outcome results
Unaided Visual Acuity After the Procedure
visual acuity (vision of the patient) without use of any glasses measured using LogMar charts. This measure has no specified units
Time frame: 1-2 years after the surgery
Population: Those are participants with complete data and were considered for final statistical analysis
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Traditional OVD Group | Unaided Visual Acuity After the Procedure | 0.264 LogMar vision | Standard Deviation 0.17 |
| Reduced OVD Group | Unaided Visual Acuity After the Procedure | 0.227 LogMar vision | Standard Deviation 0.12 |
Intraocular Pressure Postoperatively
intraocular pressure in mmHg as measured by non-contact airpuff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan). intraocular pressure is measured in millimeters of mercury
Time frame: first day, first week and first month after the procedure
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Traditional OVD Group | Intraocular Pressure Postoperatively | 17.44 mmHg | Standard Deviation 4.46 |
| Reduced OVD Group | Intraocular Pressure Postoperatively | 17.80 mmHg | Standard Deviation 4.58 |
Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells
The standard deviation of the mean cell area divided by the mean cell area gives the coefficient of variation, a unitless number that is normally less than 0.30. it reflects the health of endothelial cells and measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan).
Time frame: 1-2 years after the surgery
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Traditional OVD Group | Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells | 27.37 uniteless | Standard Deviation 3.76 |
| Reduced OVD Group | Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells | 29.64 uniteless | Standard Deviation 3.85 |
Specular Microscopy Parameter: Endothelial Cell Density
defined as the number of corneal endothelial cells per square millimeter of area, measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)
Time frame: 1-2 years after the surgery
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Traditional OVD Group | Specular Microscopy Parameter: Endothelial Cell Density | 2785.4 cells per square millimeter | Standard Deviation 417.1 |
| Reduced OVD Group | Specular Microscopy Parameter: Endothelial Cell Density | 2851.0 cells per square millimeter | Standard Deviation 305.1 |
Specular Microscopy Parameter: Endothelial Cells Hexagonality
defined as the percentage of endothelial cells having 6 borders and shaped like a hexagon. this measure reflects the overall health of the endothelial cells and decreased hexagonality below 58-60% indicates corneal enodthelial pleomorphism, also measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)
Time frame: 1-2 years after the surgery
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Traditional OVD Group | Specular Microscopy Parameter: Endothelial Cells Hexagonality | 58.69 percentage of hexagonal cells | Standard Deviation 10.43 |
| Reduced OVD Group | Specular Microscopy Parameter: Endothelial Cells Hexagonality | 57.93 percentage of hexagonal cells | Standard Deviation 9.26 |
Postoperative Complications
such as glaucoma, cataract, persistent uveitis, macular edema, endophthalmitis..etc.
Time frame: any time post op within the maximum 2 years follow up period